Firalis - Press Releases

Press Releases

ONCOSCREEN hosts 2nd Plenary Meeting to Advance Risk-Based Colorectal Cancer Screening across Europe

12.06.2025

Launching the European Project VOLABIOS: A Breakthrough in Early Diagnosis and Monitoring of Schizophrenia

13.12.2024

Firalis Secures 1.284 M€ through France 2030 for New State-of-the-Art Bioproduction Facility in Huningue, France

26.11.2024

Amoneta Diagnostics obtains CE-marking certification under the IVDR for APO-Easy® Genotyping Kit

20.08.2024

Amoneta Diagnostics and AD Data Initiative Announce ADDIA Data on AD Workbench

12.12.2023

Bpifrance funds Firalis’ Alzheimer Project!

FIRALIS’ Research on Neurodegenerative Diseases obtains Bpifrance Funding!

09.08.2022

FIRALIS obtains ISO 14001 International Quality Standard !

FIRALIS obtained the AFNOR certification “ISO 14001”, a gold standard in improving the environmental performance!

11.07.2022

HAS valide le remboursement d'EasyCOV*

*La Haute Autorité de Santé (HAS) valide l’utilisation et recommande le remboursement du test salivaire EasyCOV® sous conditions.

28.11.2020

TACKLING COVID-19: THE "COVIRNA" PROJECT

A diagnostic test funded by the EU, to improve surveillance and care of COVID-19 patients

27.11.2020

EasyCov: Covid-19 saliva test

Firalis-produced and CE-marked "EasyCOV" saliva test, developed by Skillcell

18.06.2020

Theranostic Tool

13.03.2020

EU-funded (Eurostars) HeartLinc Program

13.03.2020

Launch of the Biopred panel

13.03.2020

Launch of the FiMICS® panel

13.03.2020

Fundraising by Amoneta Diagnostics

13.03.2020

USD 2 million by the Alzheimer’s Drug Discovery Foundation ...

13.03.2020

Champions de la croissance 2020

Firalis is placed as the 229th fastest growing French business in 2020, among 10k participants, as a result of a selection by the partnership of "Les Echos" and "Statista".

13.03.2020

Amoneta closes 2019 with fundraising of EUR 2.2 million

11.01.2020